Longman S.D., Hamilton T.C. (1992) Potassium channel activator drugs: Mechanism of action, pharmacological properties therapeutic potential. Med. Res. Rev. 12:73-148.
Weston A.H., Edwards G. (1992) Recent progress in potassium channel opener pharmacology. Biochem. Pharmacol. 43:47-54.
Antoine M.-H., Berkenboom G., Fang Z.-Y., Fontaine J., Herchuelz A., Lebrun P. (1992) Mechanical ionic response of rat aorta to diazoxide. Eur. J. Pharmacol. 216:299-306.
Lebrun P., Devreux V., Hermann M., Herchuelz A. (1989) Similarities between the effects of pinacidil and diazoxide on ionic secretory events in rat pancreatic islets. J. Pharmacol. Exp. Ther. 250:1011-1018.
Lebrun P., Antoine M.H., Devreux V., Hermann M., Herchuelz A. (1990) Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells. J. Pharmacol. Exp. Ther. 255:948-953.
Lebrun P., Fang Z.Y., Antoine M.H., Herchuelz A., Hermann M., Berkenboom G., Fontaine J. (1990) Hypoglycemic sulfonylureas antagonize the effects of cromakalim pinacidil on 86Rb fluxes and contractile activity in the rat aorta. Pharmacology 41:36-48.
Pirotte B., De Tullio P., Lebrun P., Antoine M.H., Fontaine J., Masereel B., Schynts M., Dupont L., Herchuelz A., Delarge J. (1993) 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic b-cells: A new class of potassium channel openers?. J. Med. Chem. 36:3211-3213.
De Tullio P., Pirotte B., Lebrun P., Fontaine J., Dupont L., Antoine M.-H., Ouedraogo R., Khelili S., Maggetto C., Masereel B., Diouf O., Podona T., Delarge J. (1996) 3- and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: Synthesis pharmacological evaluation structure-activity relationships. J. Med. Chem. 39:937-948.
Pirotte B., Antoine M.-H., De Tullio P., Hermann M., Herchuelz A., Delarge J., Lebrun P. (1994) A pyridothiadiazine (BPDZ 44) as a new potent activator of ATP-sensitive K+ channels. Biochem. Pharmacol. 47:1381-1386.
Lebrun P., Antoine M.-H., Ouedraogo R., Dunne M., Kane C., Hermann M., Herchuelz A., Masereel B., Delarge J., De Tullio P., Pirotte B. (1996) Activation of ATP-dependent K+ channels inhibition of insulin release: Effect of BPDZ 62. J. Pharmacol. Exp. Ther. 277:156-162.
Antoine M.-H., Pirotte B., Hermann P., De Tullio P., Delarge J., Herchuelz A., Lebrun P. (1994) Cationic secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets. Experientia 50:830-832.
Khelili S., De Tullio P., Lebrun P., Fillet M., Antoine M.-H., Ouedraogo R., Dupont L., Fontaine J., Felekidis A., Leclerc G., Delarge J., Pirotte B. (1999) Preparation pharmacological evaluation of the R- and S-enantiomers of 3-(2′-butylamino)-4H- and 3-(3′-methyl-2′-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers. Bioorg. Med. Chem. 7:1513-1520.
Hess H.J., Cronin T.H., Scriabine A. (1968) Antihypertensive 2-amino-4(3H)-quinazolinones. J. Med. Chem. 11:130-137.
Empfield J.R., Russell K. (1995) Potassium channel openers. Annu. Rep. Med. Chem. 30:81-90.
Erb B., Akue R., Rigo B., Pirotte B., Couturier D. (2000) Synthesis of 2-aminoquinazolin-4(3H)-ones as potential potassium channel openers. J. Heterocycl. Chem. 37:253-260.
Lebrun P., Devreux V., Hermann M., Herchuelz A. (1988) Pinacidil inhibits insulin release by increasing K+ outflow from pancreatic B-cells. Eur. J. Pharmacol. 156:283-286.
Quayle J.M., Nelson M.T., Standen N.B. (1997) ATP-sensitive inwardly rectifying potassium channels in smooth muscle. Physiol. Rev. 77:1165-1232.
Sun Y.D., Benishin C.G. (1994) K+ channel openers relax longitudinal muscle of guinea pig ileum. Eur. J. Pharmacol. 271:453-459.
Davies M.P., McCurrie J.R., Wood D. (1996) Comparative effects of K+ channel modulating agents on contractions of rat intestinal smooth muscle. Eur. J. Pharmacol. 297:249-256.
Lebrun P., Arkhammar P., Antoine M.-H., Nguyen Q.-A., Bondo-Hansen J., Pirotte B. (2000) A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 43:723-732.
Ouedraogo R., Fontaine J., Antoine M.-H., Pirotte B., Lebrun P. (2000) Effects of 3-alkylamino-7-chloro-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides on smooth muscle contraction. Pharm. Pharmacol. Commun. 6:97-100.
Pirotte B., Ouedraogo R., De Tullio P., Khelili S., Somers F., Boverie S., Dupont L., Fontaine J., Damas J., Lebrun P. (2000) 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: Design synthesis pharmacological evaluation. J. Med. Chem. 43:1456-1466.
Bandoli G., Nicolini M. (1977) Crystal and molecular structure of diazoxide an antihypertensive agent. J. Cryst. Mol. Struct. 7:229-240.
Pirotte B., De Tullio P., Masereel B., Schynts M., Delarge J. (1993) Structural study of pinacidil, a potassium channel opener belonging to the chemical class of N-alkyl-N″-cyano-N′-pyridylguanidines. Helv. Chim. Acta 16:1311-1318.
Leclercq-Meyer V., Marchand J., Woussen-Colle M.C., Giroix M.-H., Malaisse W.J. (1985) Multiple effects of leucine on glucagon, insulin, and somatostatin secretion from the perfused rat pancreas. Endocrinology 116:1168-1174.
Paton W.D.M. (1955) The response of guinea pig ileum to electrical stimulation by coaxial electrodes. J. Physiol. 127.
Sheldrick G.M. SHELXS 97, A Program for the Solution of Crystal Structures, University of Göttingen, Göttingen, Germany; 1997.
Sheldrick G.M. SHELXL 97, A Program for the Refinement of Crystal Structures from Diffraction Data, University of Göttingen, Göttingen, Germany; 1997.
Hahn Th. International Tables for X-ray Crystallography , Reidel Publishing Company: Dordrecht; The Netherlands; Tables 4.2.6.8 and 6.1.1.4; 1992, C.
Burnett M.N., Johnson C.K. ORTEP-III; Oak Ridge Thermal Ellipsoid Plot Program for Crystal Structure Illustrations, Report ORNL-6895; Oak Ridge National Laboratory: Oak Ridge, TN; 1996.
